Clear Street’s EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share EQHA.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-61,300
Closed -$4K 1598
2022
Q3
$4K Buy
61,300
+300
+0.5% +$30 ﹤0.01% 867
2022
Q2
$6K Buy
+61,000
New +$12.6K ﹤0.01% 678

Other funds holding EQHA.WS

Clear Street's EQHA.WS Position: Q4 2022 in Review

Clear Street sold out of EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share (EQHA.WS) in Q4 2022, closing a stake of 61,300 shares — an estimated $4K sold.

Clear Street first reported a position in EQHA.WS in Q2 2022 and held it in 2 quarters. The position peaked at $6K in Q2 2022. 1 fund tracked by Wall St. Rank holds EQHA.WS as of Q4 2022.

  • Clear Street reported no remaining EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share position as of Q4 2022 after selling out during the quarter.
  • Clear Street sold 61,300 EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share shares in Q4 2022, an estimated $4K.
  • Clear Street first reported a position in EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share in Q2 2022 and held it in 2 quarters.
  • Clear Street's EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share position peaked at $6K in Q2 2022.
  • 1 fund tracked by Wall St. Rank held EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share as of Q4 2022.

Based on Clear Street's 13F filing for Q4 2022, filed 13 Feb 2023.